These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 7712528)

  • 21. Susceptibility of human breast epithelial cells in vitro to hormones and drugs.
    Calaf GM
    Int J Oncol; 2006 Feb; 28(2):285-95. PubMed ID: 16391781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Drug therapy of endometriosis].
    Wenzl R; Jirecek S; Huber J
    Wien Med Wochenschr; 1999; 149(13):372-3, 376. PubMed ID: 10568019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormonal treatment of endometrial cancer: past, present and future.
    Podczaski E; Mortel R
    Best Pract Res Clin Obstet Gynaecol; 2001 Jun; 15(3):469-89. PubMed ID: 11476566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Danazol in the treatment of mammary dysplasia.
    Greenblatt B; Ben-Nun I
    Drugs; 1980 May; 19(5):349-55. PubMed ID: 6993181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of danazol in the treatment of benign mastopathies].
    De Noblens C
    Rev Fr Gynecol Obstet; 1992 Nov; 87(11):564-6. PubMed ID: 1480927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hormone therapy of metastasizing breast carcinoma].
    Hagen MF; Thürlimann B
    Ther Umsch; 1996 Nov; 53(11):820-8. PubMed ID: 8984687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Update in the therapy of fibrocystic mastopathy].
    Zanoio L; Zacché G; Mainenti M; Silvestre V
    Minerva Ginecol; 1987 Dec; 39(12):833-8. PubMed ID: 3329703
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hormonal stimulation of reproductive function in swine].
    Hladkova AI
    Fiziol Zh (1978); 1993; 39(5-6):99-108. PubMed ID: 8045325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of mastodynia and mastopathy].
    Presl J
    Cesk Gynekol; 1982 May; 47(4):285-7. PubMed ID: 7094060
    [No Abstract]   [Full Text] [Related]  

  • 30. [Mastodynia and fibrocystic disease of the breast. Perspectives and methods of medical treatment].
    van Bogaert LJ
    J Gynecol Obstet Biol Reprod (Paris); 1986; 15(6):805-11. PubMed ID: 3794218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endometriosis.
    Gutmann JN; DeCherney AH
    Curr Ther Endocrinol Metab; 1994; 5():232-7. PubMed ID: 7704722
    [No Abstract]   [Full Text] [Related]  

  • 32. Advances in the management of endometriosis: an update for clinicians.
    Crosignani P; Olive D; Bergqvist A; Luciano A
    Hum Reprod Update; 2006; 12(2):179-89. PubMed ID: 16280355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of pain in endometriosis.
    Erny R; Guidicelli B
    Contrib Gynecol Obstet; 1987; 16():205-11. PubMed ID: 3319391
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hormone treatment of benign breast diseases].
    Mauvais-Jarvis P
    Bull Cancer; 1991; 78(4):365-71. PubMed ID: 1859904
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of hormone therapy on the endometrium.
    Deligdisch L
    Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hormonal therapy of breast cancer].
    Espié M
    Bull Cancer; 1994; 81(10 Suppl):5-7. PubMed ID: 7718950
    [No Abstract]   [Full Text] [Related]  

  • 37. [Diagnosis and treatment of mastodynia].
    Genolet PM; Delaloye JF; De Grandi P
    Rev Med Suisse Romande; 1995 May; 115(5):385-90. PubMed ID: 7770685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Possibilities of hormonal treatment of endometrial carcinoma].
    Kopecný J; Rejthar A
    Cesk Gynekol; 1990 Jul; 55(6):447-51. PubMed ID: 2208320
    [No Abstract]   [Full Text] [Related]  

  • 39. A comprehensive review of the safety and efficacy of bioidentical hormones for the management of menopause and related health risks.
    Moskowitz D
    Altern Med Rev; 2006 Sep; 11(3):208-23. PubMed ID: 17217322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
    Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
    Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.